GRI Bio

GRI · NASDAQ

$1.46+$0.01 (+0.69%)TodayMarket closed ·
Prev close $1.45

Latest news

  • Press releaseGlobe Newswire

    GRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF at the 10th IPF Summit

  • News

    UPDATED: Watching GRI Bio; Zacks Investment Research Upgrades Stock To Buy

  • Press releaseGlobe Newswire

    GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • Press releaseGlobe Newswire

    GRI Bio Featured in "Why Now" On-Demand Video Webcast

  • Press releaseGlobe Newswire

    GRI Bio to Present Late-Breaking Phase 2a GRI-0621 Data Highlighting Lung Function, Anti-Fibrotic Biomarkers and Favorable Tolerability in IPF at ERS 2026

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    GRI Bio Says FDA Grants Orphan Drug Designation To GRI-0621 For Treatment Of Idiopathic Pulmonary Fibrosis, Irreversible And Ultimately Fatal Lung Disease

  • Press releaseGlobe Newswire

    GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis

  • Press releaseGlobe Newswire

    GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase

  • Press releaseGlobe Newswire

    GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline

  • Press releaseGlobe Newswire

    GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial

  • Press releaseGlobe Newswire

    GRI Bio Reiterates Full Year 2025 Financial Results, Strengthens Balance Sheet and Summarizes Key Recent Highlights

  • NewsAvi Kapoor

    Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

  • NewsVandana Singh

    GRI Bio Drug Shows Promising Lung Function Recovery In Patients With Thickened Lungs

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsAvi Kapoor

    Why Adobe Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • NewsAvi Kapoor

    Crude Oil Falls 1%; Meta Earnings Top Views

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsAvi Kapoor

    Nasdaq Surges Over 1%; Microsoft Posts Upbeat Earnings

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • NewsAvi Kapoor

    Dow Falls Over 150 Points; General Motors Tops Q3 Views

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • NewsAvi Kapoor

    Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    US Stocks Edge Lower; Dow Falls 50 Points

  • NewsAvi Kapoor

    Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Why DocuSign Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.